Skip to main navigation Skip to search Skip to main content

Comparative Effectiveness and Safety of Moderate-Intensity Pravastatin Versus Atorvastatin in Patients with Dyslipidemia: A Retrospective Cohort Study Using a Common Data Model of Multicenter Electronic Health Records in South Korea

  • Sung Wan Chun
  • , Hae Jin Kim
  • , Ji A. Seo
  • , Suk Chon
  • , Sung Eun Kim
  • , Jung Hwa Jung
  • , Sang Soo Kim
  • , Hyejin Lee
  • , Sanghoon Shin
  • , So Hun Kim
  • , Dughyun Choi
  • , Hyeong Kyu Park
  • , Soo Kyung Kim
  • , Ji Hwan Bae
  • , In Kyung Jeong

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Aim: To compare the effectiveness and safety of moderate-intensity pravastatin 40 mg/day and atorvastatin 10 mg/day in patients with dyslipidemia. Methods: We conducted a retrospective cohort study using electronic health records of 19 million patients across 14 secondary/tertiary hospitals, standardized to a Common Data Model. New users of pravastatin (40 mg/ day) and atorvastatin (10 mg/day) were identified. Six distinct cohorts were used to assess the comparative effectiveness in preventing major adverse cardiovascular events (MACE) and the risks of new-onset diabetes mellitus (NODM), myalgia or rhabdomyolysis, and hepatotoxicity (measured by aspartate aminotransferase [AST]/alanine aminotransferase [ALT]). Propensity score matching (PSM) was applied to each cohort for effectiveness and safety analyses, followed by a meta-analysis of hospital-specific results.

Original languageEnglish
Pages (from-to)1268-1303
Number of pages36
JournalJournal of Atherosclerosis and Thrombosis
Volume32
Issue number10
DOIs
StatePublished - 2025

Bibliographical note

Publisher Copyright:
Copyright©2025 Japan Atherosclerosis Society.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Atorvastatin
  • Hepatotoxicity
  • MACE
  • Pravastatin
  • Real-world practice

Fingerprint

Dive into the research topics of 'Comparative Effectiveness and Safety of Moderate-Intensity Pravastatin Versus Atorvastatin in Patients with Dyslipidemia: A Retrospective Cohort Study Using a Common Data Model of Multicenter Electronic Health Records in South Korea'. Together they form a unique fingerprint.

Cite this